Programme

Day 1 - Wednesday 28 June 2017

08:00
Opening registration, exhibition & light breakfast
Exhibition
09:00
Workshop on robotic surgery
Main auditorium
11:00
Coffee break & poster viewing
Exhibition
11:30
Official opening on behalf of local and global organising committee
Main auditorium
11:45
Opening lecture
Main auditorium
11:45
Neuroendocrine prostate cancer: what does it mean?
Main auditorium
12:30
Lunch break & poster viewing
Exhibition
13:30
Diagnosis of PCa: imaging and biomarkers
Main auditorium
13:30
Should MRI be performed in every patient with an elevated PSA?
Main auditorium
13:50
Biomarkers in 2017
Main auditorium
14:20
Clinical case discussions including supporting evidence
Main auditorium
15:10
Q&A
Main auditorium
15:30
Coffee break & poster viewing
Exhibition
16:00
ISSECAM Forum GU Oncology - Prostate Cancer
Main auditorium
16:00
Selection of highlights from EAU & ASCO GU
Main auditorium
16:30
Selection of highlights from AUA & ASCO
Main auditorium
17:00
Q&A
Main auditorium
17:20
State-of-the-art lecture
Main auditorium
17:20
Screening for prostate cancer: where do we stand?
Main auditorium
18:00
Welcome drink
Exhibition
19:00
End of day
Exhibition

Day 2 - Thursday 29 June 2017

08:00
Opening registration, exhibition & light breakfast
Exhibition
08:20
Welcome
Main auditorium
08:30
Active surveillance or active treatment for low and favourable intermediate-risk PCa
Main auditorium
08:30
Mirrors of Medicine case discussion: A or B?
Main auditorium
08:45
Lessons from PROTECT
Main auditorium
09:05
Active surveillance for Gleason 7, option or heresy?
Main auditorium
09:25
Q&A
Main auditorium
09:50
State-of-the-art lecture
Main auditorium
09:50
Hormone therapy beyond 2017
Main auditorium
10:30
Coffee break & poster viewing
Exhibition
11:00
Technology in PCa: state-of-the-art
Main auditorium
11:00
Robotic prostatectomy: a great opportunity for quality assurance development
Main auditorium
11:20
What is the role of brachytherapy in 2017?
Main auditorium
11:40
Technology, dose and schedule: state-of-the-art in 2017
Main auditorium
12:00
Q&A
Main auditorium
12:30
Lunch break & poster viewing
Main auditorium
13:30
Advanced PCa
Main auditorium
13:30
APCCC St. Gallen 2017: what’s new?
Main auditorium
14:00
The role of chemotherapy in 2017
Main auditorium
14:30
AR-pathway inhibitors: where do we stand in 2017?
Main auditorium
15:00
Q&A
Main auditorium
15:30
Coffee break & poster viewing
Exhibition
16:00
Newly diagnosed N+M+
Main auditorium
16:00
Clinical case discussions including supporting evidence
Main auditorium
17:30
End of day
Main auditorium

Day 3 - Friday 30 June 2017

08:00
Opening registration, exhibition & light breakfast
Exhibition
08:20
Welcome
Main auditorium
08:30
Locally advanced and oligo-metastatic disease
Main auditorium
08:30
Performance of whole-body MRI / PET in detecting oligo-metastastic disease
Main auditorium
08:50
Treatment of oligo-metastatic PCa: are we chasing Pokemons?
Main auditorium
09:10
sEBRT for oligo-metastastic prostate cancer: targeted or loco-regional?
Main auditorium
09:30
Q&A
Main auditorium
10:00
State-of-the-art lecture
Main auditorium
10:00
The role of bone-targeted therapies in 2017
Main auditorium
10:40
Coffee break & poster viewing
Exhibition
11:10
Best poster session
Main auditorium
11:50
Vision on the future
Main auditorium
11:50
Medical oncologist
Main auditorium
12:10
Radiation oncologist
Main auditorium
12:30
Urologist
Main auditorium
12:50
Q&A
Main auditorium
13:00
Close & farewell
Main auditorium
13:15
End of day
Main auditorium
  • Keynote lecture
  • Clinical case discussions
  • Active debate